Publication | Closed Access

Bioinformatics-based discovery and characterization of an AKT-selective inhibitor 9-chloro-2-methylellipticinium acetate (CMEP) in breast cancer cells

Breast OncologyBreast Cancer CellsCancer GenomicsBioinformatics-based DiscoveryBreast CancerAnti-cancer AgentSystems BiologyMedicineRadiation OncologyAkt-selective Inhibitor 9-Chloro-2-methylellipticiniumTumor MicroenvironmentDrug Discovery